Builders FirstSource, Inc. BLDR 深 沪
等待开盘 03-26 09:30:00 美东时间
85.41
+1.470
+1.75%
华盛通- 最 高86.84
- 今 开85.85
- 成交量 168.08万股
- 最 低 81.915
- 昨 收 83.94
- 总市值 94.81亿
- 52周最高 151.03
- 市盈率 静 21.95
- 换手率 0.00%
- 52周最低 80.00
- 委 比 39.86%
- 总股本 1.11亿
- 历史最高 214.70
- 量 比 0.69
- 振 幅 5.87%
- 历史最低 1.01
- 每 手 1
- 风险率 13.26%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多10 War-Beaten Stocks Rally Monday On Trump Truce Talk—Despite Iran Denial
Iran's Foreign Ministry swiftly rejected claims from the Trump administration about active peace talks, yet the market rallies.
03-23 22:36
美股大行评级 | 能源股获大行青睐！美国铝业、康索尔能源、康菲石油、EOG能源等获上调目标价；多只航空股遭下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Altimmune"买入"评级，目标价从12美元升至25美元；BTIG：维持Jade Biosciences"买入"评级，目标价从28美元升至39美元
03-17 11:45
Micron To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Monday
Top analysts updated ratings for MU, EPAM, WLTH, OKUR, BLDR, DMRC, JBIO, CRCL. See changes and ratings on analyst ratings page.
03-16 20:12
Stifel Maintains Hold on Builders FirstSource, Lowers Price Target to $93
Stifel analyst W. Andrew Carter maintains Builders FirstSource (NYSE:BLDR) with a Hold and lowers the price target from $115 to $93.
03-16 19:18
美股大行评级 | 最高582美元！博通获多家机构上调目标价；GENI、Okta、Rigetti Computing、Veeva Systems、Wix.com遭多家机构下调目标价
今日重点评级关注：韦德布什：维持TScan Therapeutics"跑赢大市"评级，目标价从4美元升至5美元；HC Wainwright & Co.：维持莱斯康制药"买入"评级，目标价从4美元升至6美元
03-06 11:58
RBC Capital Upgrades Builders FirstSource to Outperform, Maintains Price Target to $119
RBC Capital analyst Mike Dahl upgrades Builders FirstSource (NYSE:BLDR) from Sector Perform to Outperform and maintains the price target from $119 to $119.
03-05 23:16
William Blair Initiates Coverage On Builders FirstSource with Outperform Rating
William Blair analyst Ryan Merkel initiates coverage on Builders FirstSource (NYSE:BLDR) with a Outperform rating.
02-26 22:45
美股大行评级 | 潜在涨幅214.14%！HC Wainwright & Co.：Ardelyx获机构升目标价至18美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Ardelyx"买入"评级，目标价从10美元升至18美元；Truist Securities：维持Praxis Precision Medicine"买入"评级，目标价从500美元升至700美元
02-23 08:56
Barclays Maintains Overweight on Builders FirstSource, Lowers Price Target to $124
Barclays analyst Matthew Bouley maintains Builders FirstSource (NYSE:BLDR) with a Overweight and lowers the price target from $136 to $124.
02-20 23:09
美股大行评级 | 潜在涨幅216.49%！杰富瑞上调BioAge Labs目标价至62美元，评级升至"买入"
今日重点评级关注：杰富瑞：上调BioAge Labs评级至"买入"，目标价从9美元升至62美元；RBC Capital：维持COMPASS Pathways Plc Sponsored ADR"跑赢大市"评级，目标价从21美元升至22美元
02-19 16:21
